These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8805713)

  • 1. Provision of prescription drug info mandated.
    Marwick C
    JAMA; 1996 Sep; 276(12):935. PubMed ID: 8805713
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Am J Hosp Pharm; 1993 Jan; 50(1):13, 16. PubMed ID: 8427271
    [No Abstract]   [Full Text] [Related]  

  • 3. Importing prescription drugs: risky business.
    Hassel L; Arzuaga P
    Empl Benefits J; 2003 Dec; 28(4):83-6. PubMed ID: 14712740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legal considerations in off-label medication prescribing.
    Blum RS
    Arch Intern Med; 2002 Aug 12-26; 162(15):1777-9. PubMed ID: 12153383
    [No Abstract]   [Full Text] [Related]  

  • 5. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for FDA-approved patient information spelled out in final rule.
    Am J Health Syst Pharm; 1999 Jan; 56(2):107-8. PubMed ID: 10030523
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Clin Pharm; 1993 Jan; 12(1):6. PubMed ID: 8428434
    [No Abstract]   [Full Text] [Related]  

  • 8. MedGuide: at last a long-sought opportunity for patient education about prescription drugs.
    Marwick C
    JAMA; 1997 Mar; 277(12):949-50. PubMed ID: 9091654
    [No Abstract]   [Full Text] [Related]  

  • 9. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA requires boxed warning for all immediate-release opioid products.
    Thompson CA
    Am J Health Syst Pharm; 2016 May; 73(9):e114-5. PubMed ID: 27099322
    [No Abstract]   [Full Text] [Related]  

  • 11. Rx with a dose of info.
    Miller RW
    FDA Consum; 1980 Nov; 14(9):22-3. PubMed ID: 10309292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What drug labels don't tell you.
    Consum Rep; 2011 Aug; 76(8):10. PubMed ID: 21770080
    [No Abstract]   [Full Text] [Related]  

  • 13. Off-label prescribing and the standard of care.
    Johnson LJ
    Med Econ; 2001 Aug; 78(16):97. PubMed ID: 11550443
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 15. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug information leaflets for consumers need improvement, FDA says.
    Traynor K
    Am J Health Syst Pharm; 2002 Aug; 59(16):1498, 1501. PubMed ID: 12185823
    [No Abstract]   [Full Text] [Related]  

  • 17. Should expiration dates be required on patients' prescription labels?
    Hadeler F
    Am Pharm; 1986 Aug; NS26(8):30-5. PubMed ID: 3776829
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 20. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
    Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.